Nancy C. Santanello

Biography

Currently, she consults for the PhRMA Foundation programs on outcomes research and comparative effectiveness. Dr. Santanello also sits on the Biopharma External Advisory Board of the University of Medicine and Dentistry of New Jersey and the Arcadia University MPH Program Advisory Board. Dr. Santanello is a physician-epidemiologist trained in Emergency Medicine and Preventive Medicine with a Masters of Science degree in Epidemiology. Dr. Santanello received her M.D. from Howard University and her M.S. from the University of Maryland. Dr. Santanello’s areas of research interest include: the development and validation of outcome measures for use in clinical trials, trial and observational study design, adherence to therapy, satisfaction with and preference for therapy, clinical outcome assessments, patient reported outcomes, effectiveness studies, and drug and vaccine safety/ pharmacoepidemiology. Dr. Santanello was a Medical Officer with the National Heart, Lung, and Blood Institute (NHLBI) Prevention and Demonstration Research Branch of the Division of Epidemiology and Clinical Applications conducting clinical trials, epidemiology studies and developing physician training and patient education materials. In 1991, Dr. Santanello joined Merck & Co. Inc. where she became the Vice President and Head of the Epidemiology Department. In 1998 Dr. Santanello received the Merck Board of Directors Award, the Company’s highest honor, for her work in support of clinical and outcomes research measures for asthma. She is a Past President of the International Society for Pharmacoepidemiology (ISPE) and is a Fellow of ISPE (FISPE). She is a past member of the IMEDS Scientific Advisory Committee. Dr. Santanello has been invited to speak at national and international meetings, including the Institute of Medicine, Brookings Institute, the US Food and Drug Administration, International Society of Quality of Life, ISPE, Asia Pacific Conference on Pharmacoepidemiology, American Thoracic Society, NIH PROMIS, China Society for Evidence Based Medicine, and the China FDA. Dr. Santanello has published over 60 peer-reviewed manuscripts

Research Interest

epidemiology, pharmacoepidemiology